|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.986
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.984
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.918
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.825
|
Mouse |
|
|
chromatin modification
|
GO:0016568 |
187 |
0.818
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.798
|
Human |
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.736
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.721
|
Mouse |
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.634
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.623
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.609
|
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.605
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.603
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.598
|
Mouse |
|
|
histone modification
|
GO:0016570 |
159 |
0.565
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.443
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.442
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.435
|
Mouse |
|
|
histone methylation
|
GO:0016571 |
71 |
0.432
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.419
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.416
|
Human |
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.405
|
Worm |
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.369
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.361
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.361
|
|
|
|
nucleosome disassembly
|
GO:0006337 |
1 |
0.357
|
|
|
|
protein dna complex disassembly
|
GO:0032986 |
1 |
0.356
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.337
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.337
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.336
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.314
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.311
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.306
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.265
|
Mouse |
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.261
|
Mouse |
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.258
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.251
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.248
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.243
|
Human |
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.236
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.229
|
Human |
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.227
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.218
|
Worm |
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.207
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.205
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.204
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.203
|
Human Mouse |
|
|
protein methylation
|
GO:0006479 |
81 |
0.203
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.200
|
Human |
|
|
histone h4 k12 acetylation
|
GO:0043983 |
2 |
0.200
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.195
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.195
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.188
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.186
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.186
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.185
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.183
|
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.178
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.176
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.173
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.170
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.169
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.168
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.164
|
Mouse |
|
|
lipid localization
|
GO:0010876 |
126 |
0.161
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.155
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.148
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.146
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.145
|
Human |
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.143
|
Human |
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.142
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.140
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.138
|
Human |
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.137
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.136
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.135
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.131
|
Fly |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.126
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.124
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.124
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.123
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.122
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.121
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.117
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.115
|
Human |
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.111
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.110
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.110
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.107
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.103
|
|
|
|
hypermethylation of cpg island
|
GO:0044027 |
3 |
0.103
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.101
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.099
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.097
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.097
|
|
|
|
dna methylation involved in gamete generation
|
GO:0043046 |
15 |
0.096
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.095
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.095
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.094
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.094
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.094
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.093
|
Mouse |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.093
|
Human |
|
|
chromatin disassembly
|
GO:0031498 |
1 |
0.092
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.091
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.091
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.090
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.088
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.088
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.088
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.087
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.087
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.085
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.085
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.085
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.083
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.082
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.082
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
9 |
0.082
|
Human |
|
|
rhythmic process
|
GO:0048511 |
174 |
0.081
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.081
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.080
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.079
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.078
|
Human |
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.078
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.078
|
|
|
|
n terminal protein amino acid modification
|
GO:0031365 |
6 |
0.077
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.077
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.075
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.074
|
Human |
|
|
histone h3 k14 acetylation
|
GO:0044154 |
3 |
0.074
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.074
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.073
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.073
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.073
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.072
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.072
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.070
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.070
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.070
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.069
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.069
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.069
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.068
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.067
|
Mouse |
|
|
oogenesis
|
GO:0048477 |
56 |
0.067
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.066
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.065
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.065
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.065
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.064
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.064
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.063
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.062
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.062
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.061
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.060
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.059
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.059
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.059
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.059
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.059
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.058
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.058
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.058
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.058
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.057
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.057
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.057
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
18 |
0.056
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.056
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.056
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.056
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.056
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.056
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.055
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.055
|
Mouse |
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.055
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.054
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.054
|
Human |
|
|
positive regulation of mrna 3 end processing
|
GO:0031442 |
5 |
0.054
|
|
|
|
regulation of mrna 3 end processing
|
GO:0031440 |
6 |
0.054
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.053
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.053
|
|
|
|
negative regulation of cell growth involved in cardiac muscle cell development
|
GO:0061052 |
2 |
0.053
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.053
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.052
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.052
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.051
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.051
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.051
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.050
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.049
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.049
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.049
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.049
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.049
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.049
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.049
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.049
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.048
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.047
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.047
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.047
|
Mouse |
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.046
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.046
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.046
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.045
|
Fly |
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.045
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.045
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.045
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.045
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.045
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.044
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.044
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.044
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.044
|
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
17 |
0.044
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.044
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.044
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.044
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.043
|
Mouse |
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.043
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.043
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.042
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.042
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.042
|
Mouse |
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.042
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.042
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.042
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.041
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.041
|
|
|
|
memory
|
GO:0007613 |
58 |
0.040
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.040
|
|
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
9 |
0.040
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.040
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.040
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
21 |
0.039
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.039
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.038
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.038
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.038
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.038
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.038
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.038
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.037
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.037
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.037
|
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
16 |
0.037
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.036
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.036
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.036
|
|
|
|
pre mirna processing
|
GO:0031054 |
3 |
0.036
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.036
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.036
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.036
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.036
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.035
|
Mouse |
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.035
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.035
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.035
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.035
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.035
|
|
|
|
locomotor rhythm
|
GO:0045475 |
8 |
0.035
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.034
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.034
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.034
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.034
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.033
|
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
16 |
0.033
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.033
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.033
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.033
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.033
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.033
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.033
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.033
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.033
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.032
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.032
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.032
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.032
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.032
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.032
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.032
|
|
|
|
cerebellar purkinje cell layer morphogenesis
|
GO:0021692 |
14 |
0.032
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.032
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.032
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.031
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.031
|
Human |
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.031
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.031
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.031
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.031
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.030
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.030
|
|
|
|
regulation of clathrin mediated endocytosis
|
GO:2000369 |
4 |
0.030
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.030
|
|
|
|
germ cell migration
|
GO:0008354 |
8 |
0.030
|
|
|
|
thick ascending limb development
|
GO:0072023 |
2 |
0.030
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.030
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.029
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.029
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.029
|
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.029
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.029
|
|
|
|
positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900153 |
5 |
0.029
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.029
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.029
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.028
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.028
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.028
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.028
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.028
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.028
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.028
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.028
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.028
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.027
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.027
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.027
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.027
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.027
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.027
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.026
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.026
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.026
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.026
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.026
|
Worm |
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.026
|
|
|
|
learning
|
GO:0007612 |
98 |
0.026
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.026
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.026
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.025
|
|
|
|
production of sirna involved in rna interference
|
GO:0030422 |
1 |
0.025
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.025
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.025
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.025
|
|
|
|
dna hypermethylation
|
GO:0044026 |
3 |
0.025
|
|
|
|
trna wobble uridine modification
|
GO:0002098 |
2 |
0.025
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.025
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.025
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.025
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.024
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.024
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.024
|
|
|
|
regulation of mrna catabolic process
|
GO:0061013 |
6 |
0.024
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.024
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.024
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.023
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.023
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.023
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.023
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.023
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.023
|
|
|
|
nuclear transcribed mrna poly a tail shortening
|
GO:0000289 |
7 |
0.023
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.023
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.023
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.022
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.022
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.022
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.022
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.022
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.022
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.022
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.022
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.022
|
Mouse |
|
|
adult behavior
|
GO:0030534 |
135 |
0.022
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.022
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.022
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.022
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.022
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.022
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.021
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.021
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.021
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.021
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.021
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.021
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.021
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.021
|
|
|
|
regulation of neurological system process
|
GO:0031644 |
22 |
0.020
|
|
|
|
male germ line stem cell asymmetric division
|
GO:0048133 |
2 |
0.020
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.020
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.020
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.020
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.020
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.020
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.020
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.020
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.020
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.020
|
|
|
|
positive regulation of mrna catabolic process
|
GO:0061014 |
5 |
0.020
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.020
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.020
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.020
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.020
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.020
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.020
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.020
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.020
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.020
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.020
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.020
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.019
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.019
|
|
|
|
trna wobble base modification
|
GO:0002097 |
2 |
0.019
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.019
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.019
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.019
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.019
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.019
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.019
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.019
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.019
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.019
|
|
|
|
cohesin localization to chromatin
|
GO:0071921 |
1 |
0.019
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.019
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.019
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.019
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.018
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.018
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.018
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.018
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.018
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.018
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.018
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.018
|
|
|
|
cell proliferation involved in heart valve morphogenesis
|
GO:0003249 |
1 |
0.018
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.018
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.018
|
|
|
|
negative regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000587 |
2 |
0.018
|
|
|
|
negative regulation of mrna processing
|
GO:0050686 |
12 |
0.018
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.018
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.018
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.018
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.018
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.018
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.018
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.018
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.017
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.017
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.017
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.017
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.017
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
2 |
0.017
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.017
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.017
|
|
|
|
histone h4 k20 methylation
|
GO:0034770 |
8 |
0.017
|
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.017
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.017
|
Worm |
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.017
|
Human |
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.017
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.017
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.017
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.016
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.016
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.016
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.016
|
|
|
|
metanephric distal convoluted tubule development
|
GO:0072221 |
5 |
0.016
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.016
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.016
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.016
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.016
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.016
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.016
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.016
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.016
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.016
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.016
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.016
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.016
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.016
|
|
|
|
mrna transcription
|
GO:0009299 |
4 |
0.016
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.016
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.016
|
|
|
|
positive regulation of protein binding
|
GO:0032092 |
29 |
0.016
|
|
